Global Decitabine Sales Market Report 2024

Report ID: 883955 | Published Date: Jan 2025 | No. of Page: 147 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Decitabine Market Overview
    1.1 Decitabine Product Scope
    1.2 Decitabine Segment by Type
        1.2.1 Global Decitabine Sales by Type (2016 & 2021 & 2027)
        1.2.2 10 Mg Dosage Forms
        1.2.3 15 Mg Dosage Forms
        1.2.4 25 Mg Dosage Forms
    1.3 Decitabine Segment by Application
        1.3.1 Global Decitabine Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Primary MDS
        1.3.3 Secondary MDS
    1.4 Decitabine Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Decitabine Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Decitabine Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Decitabine Price Trends (2016-2027)

2 Decitabine Estimates and Forecasts by Region
    2.1 Global Decitabine Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Decitabine Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Decitabine Sales Market Share by Region (2016-2021)
        2.2.2 Global Decitabine Revenue Market Share by Region (2016-2021)
    2.3 Global Decitabine Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Decitabine Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Decitabine Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Decitabine Estimates and Projections (2016-2027)
        2.4.2 Europe Decitabine Estimates and Projections (2016-2027)
        2.4.3 China Decitabine Estimates and Projections (2016-2027)
        2.4.4 Japan Decitabine Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Decitabine Estimates and Projections (2016-2027)
        2.4.6 India Decitabine Estimates and Projections (2016-2027)
3 Global Decitabine Competition Landscape by Players
    3.1 Global Top Decitabine Players by Sales (2016-2021)
    3.2 Global Top Decitabine Players by Revenue (2016-2021)
    3.3 Global Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decitabine as of 2020)
    3.4 Global Decitabine Average Price by Company (2016-2021)
    3.5 Manufacturers Decitabine Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Decitabine Market Size by Type
    4.1 Global Decitabine Historic Market Review by Type (2016-2021)
        4.1.1 Global Decitabine Sales Market Share by Type (2016-2021)
        4.1.2 Global Decitabine Revenue Market Share by Type (2016-2021)
        4.1.3 Global Decitabine Price by Type (2016-2021)
    4.2 Global Decitabine Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Decitabine Sales Forecast by Type (2022-2027)
        4.2.2 Global Decitabine Revenue Forecast by Type (2022-2027)
        4.2.3 Global Decitabine Price Forecast by Type (2022-2027)
5 Global Decitabine Market Size by Application
    5.1 Global Decitabine Historic Market Review by Application (2016-2021)
        5.1.1 Global Decitabine Sales Market Share by Application (2016-2021)
        5.1.2 Global Decitabine Revenue Market Share by Application (2016-2021)
        5.1.3 Global Decitabine Price by Application (2016-2021)
    5.2 Global Decitabine Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Decitabine Sales Forecast by Application (2022-2027)
        5.2.2 Global Decitabine Revenue Forecast by Application (2022-2027)
        5.2.3 Global Decitabine Price Forecast by Application (2022-2027)

6 North America Decitabine Market Facts & Figures
    6.1 North America Decitabine Sales by Company
        6.1.1 North America Decitabine Sales by Company (2016-2021)
        6.1.2 North America Decitabine Revenue by Company (2016-2021)
    6.2 North America Decitabine Sales Breakdown by Type
        6.2.1 North America Decitabine Sales Breakdown by Type (2016-2021)
        6.2.2 North America Decitabine Sales Breakdown by Type (2022-2027)
    6.3 North America Decitabine Sales Breakdown by Application
        6.3.1 North America Decitabine Sales Breakdown by Application (2016-2021)
        6.3.2 North America Decitabine Sales Breakdown by Application (2022-2027)

7 Europe Decitabine Market Facts & Figures
    7.1 Europe Decitabine Sales by Company
        7.1.1 Europe Decitabine Sales by Company (2016-2021)
        7.1.2 Europe Decitabine Revenue by Company (2016-2021)
    7.2 Europe Decitabine Sales Breakdown by Type
        7.2.1 Europe Decitabine Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Decitabine Sales Breakdown by Type (2022-2027)
    7.3 Europe Decitabine Sales Breakdown by Application
        7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Decitabine Market Facts & Figures
    8.1 China Decitabine Sales by Company
        8.1.1 China Decitabine Sales by Company (2016-2021)
        8.1.2 China Decitabine Revenue by Company (2016-2021)
    8.2 China Decitabine Sales Breakdown by Type
        8.2.1 China Decitabine Sales Breakdown by Type (2016-2021)
        8.2.2 China Decitabine Sales Breakdown by Type (2022-2027)
    8.3 China Decitabine Sales Breakdown by Application
        8.3.1 China 312 Sales Breakdown by Application (2016-2021)
        8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Decitabine Market Facts & Figures
    9.1 Japan Decitabine Sales by Company
        9.1.1 Japan Decitabine Sales by Company (2016-2021)
        9.1.2 Japan Decitabine Revenue by Company (2016-2021)
    9.2 Japan Decitabine Sales Breakdown by Type
        9.2.1 Japan Decitabine Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Decitabine Sales Breakdown by Type (2022-2027)
    9.3 Japan Decitabine Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Decitabine Market Facts & Figures
    10.1 Southeast Asia Decitabine Sales by Company
        10.1.1 Southeast Asia Decitabine Sales by Company (2016-2021)
        10.1.2 Southeast Asia Decitabine Revenue by Company (2016-2021)
    10.2 Southeast Asia Decitabine Sales Breakdown by Type
        10.2.1 Southeast Asia Decitabine Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Decitabine Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Decitabine Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Decitabine Market Facts & Figures
    11.1 India Decitabine Sales by Company
        11.1.1 India Decitabine Sales by Company (2016-2021)
        11.1.2 India Decitabine Revenue by Company (2016-2021)
    11.2 India Decitabine Sales Breakdown by Type
        11.2.1 India Decitabine Sales Breakdown by Type (2016-2021)
        11.2.2 India Decitabine Sales Breakdown by Type (2022-2027)
    11.3 India Decitabine Sales Breakdown by Application
        11.3.1 India Decitabine Sales Breakdown by Application (2016-2021)
        11.3.2 India Decitabine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Decitabine Business
    12.1 Johnson & Johnson
        12.1.1 Johnson & Johnson Corporation Information
        12.1.2 Johnson & Johnson Business Overview
        12.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Johnson & Johnson Decitabine Products Offered
        12.1.5 Johnson & Johnson Recent Development
    12.2 Eli Lilly and Company
        12.2.1 Eli Lilly and Company Corporation Information
        12.2.2 Eli Lilly and Company Business Overview
        12.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Eli Lilly and Company Decitabine Products Offered
        12.2.5 Eli Lilly and Company Recent Development
    12.3 Pharmachemie B.V.
        12.3.1 Pharmachemie B.V. Corporation Information
        12.3.2 Pharmachemie B.V. Business Overview
        12.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Pharmachemie B.V. Decitabine Products Offered
        12.3.5 Pharmachemie B.V. Recent Development
    12.4 Otsuka Pharmaceutical
        12.4.1 Otsuka Pharmaceutical Corporation Information
        12.4.2 Otsuka Pharmaceutical Business Overview
        12.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Otsuka Pharmaceutical Decitabine Products Offered
        12.4.5 Otsuka Pharmaceutical Recent Development
    12.5 Sandoz
        12.5.1 Sandoz Corporation Information
        12.5.2 Sandoz Business Overview
        12.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Sandoz Decitabine Products Offered
        12.5.5 Sandoz Recent Development
    12.6 Dr Reddy's Laboratories
        12.6.1 Dr Reddy's Laboratories Corporation Information
        12.6.2 Dr Reddy's Laboratories Business Overview
        12.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Dr Reddy's Laboratories Decitabine Products Offered
        12.6.5 Dr Reddy's Laboratories Recent Development
    12.7 Accord Healthcare
        12.7.1 Accord Healthcare Corporation Information
        12.7.2 Accord Healthcare Business Overview
        12.7.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Accord Healthcare Decitabine Products Offered
        12.7.5 Accord Healthcare Recent Development
    12.8 Sun Pharmaceutical
        12.8.1 Sun Pharmaceutical Corporation Information
        12.8.2 Sun Pharmaceutical Business Overview
        12.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Sun Pharmaceutical Decitabine Products Offered
        12.8.5 Sun Pharmaceutical Recent Development
    12.9 Cipla
        12.9.1 Cipla Corporation Information
        12.9.2 Cipla Business Overview
        12.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Cipla Decitabine Products Offered
        12.9.5 Cipla Recent Development
    12.10 Lupin
        12.10.1 Lupin Corporation Information
        12.10.2 Lupin Business Overview
        12.10.3 Lupin Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Lupin Decitabine Products Offered
        12.10.5 Lupin Recent Development
    12.11 Shandong Xinshidai Pharmaceutical
        12.11.1 Shandong Xinshidai Pharmaceutical Corporation Information
        12.11.2 Shandong Xinshidai Pharmaceutical Business Overview
        12.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Shandong Xinshidai Pharmaceutical Decitabine Products Offered
        12.11.5 Shandong Xinshidai Pharmaceutical Recent Development
    12.12 Hangzhou Zhongmei Huadong Pharmaceutical
        12.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
        12.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
        12.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Products Offered
        12.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
    12.13 ZHENGDA Tianqing Pharmaceutical Group
        12.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information
        12.13.2 ZHENGDA Tianqing Pharmaceutical Group Business Overview
        12.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Products Offered
        12.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Development
    12.14 Jiangsu Aosaikang Pharmaceutical
        12.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
        12.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
        12.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Products Offered
        12.14.5 Jiangsu Aosaikang Pharmaceutical Recent Development
    12.15 Jiangsu Haosen Pharmaceutical Group
        12.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
        12.15.2 Jiangsu Haosen Pharmaceutical Group Business Overview
        12.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Products Offered
        12.15.5 Jiangsu Haosen Pharmaceutical Group Recent Development
    12.16 Lianyungang Jierui Pharmaceutical
        12.16.1 Lianyungang Jierui Pharmaceutical Corporation Information
        12.16.2 Lianyungang Jierui Pharmaceutical Business Overview
        12.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.16.4 Lianyungang Jierui Pharmaceutical Decitabine Products Offered
        12.16.5 Lianyungang Jierui Pharmaceutical Recent Development
    12.17 Qilu Pharmaceutical Hainan
        12.17.1 Qilu Pharmaceutical Hainan Corporation Information
        12.17.2 Qilu Pharmaceutical Hainan Business Overview
        12.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.17.4 Qilu Pharmaceutical Hainan Decitabine Products Offered
        12.17.5 Qilu Pharmaceutical Hainan Recent Development
    12.18 Lianyungang Runzhong Pharmaceutical
        12.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information
        12.18.2 Lianyungang Runzhong Pharmaceutical Business Overview
        12.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
        12.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Products Offered
        12.18.5 Lianyungang Runzhong Pharmaceutical Recent Development

13 Decitabine Manufacturing Cost Analysis
    13.1 Decitabine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Decitabine
    13.4 Decitabine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Decitabine Distributors List
    14.3 Decitabine Customers

15 Market Dynamics
    15.1 Decitabine Market Trends
    15.2 Decitabine Drivers
    15.3 Decitabine Market Challenges
    15.4 Decitabine Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Decitabine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Decitabine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Decitabine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Decitabine Sales (K Units) by Region (2016-2021)
    Table 5. Global Decitabine Sales Market Share by Region (2016-2021)
    Table 6. Global Decitabine Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Decitabine Revenue Share by Region (2016-2021)
    Table 8. Global Decitabine Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Decitabine Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Decitabine Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Decitabine Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Decitabine Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Decitabine Sales Share by Company (2016-2021)
    Table 14. Global Decitabine Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Decitabine Revenue Share by Company (2016-2021)
    Table 16. Global Decitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decitabine as of 2020)
    Table 17. Global Decitabine Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Decitabine Manufacturing Sites and Area Served
    Table 19. Manufacturers Decitabine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Decitabine Sales (K Units) by Type (2016-2021)
    Table 22. Global Decitabine Sales Share by Type (2016-2021)
    Table 23. Global Decitabine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Decitabine Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Decitabine Sales Share by Type (2022-2027)
    Table 26. Global Decitabine Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Decitabine Revenue Share by Type (2022-2027)
    Table 28. Global Decitabine Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Decitabine Sales (K Units) by Application (2016-2021) 
    Table 30. Global Decitabine Sales Share by Application (2016-2021)
    Table 31. Global Decitabine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Decitabine Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Decitabine Sales (K Units) by Application (2022-2027)
    Table 34. Global Decitabine Sales Share by Application (2022-2027)
    Table 35. Global Decitabine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Decitabine Revenue Share by Application (2022-2027)
    Table 37. Global Decitabine Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Decitabine Sales (K Units) by Company (2016-2021)
    Table 39. North America Decitabine Sales Market Share by Company (2016-2021)
    Table 40. North America Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Decitabine Revenue Market Share by Company (2016-2021)
    Table 42. North America Decitabine Sales by Type (2016-2021) & (K Units)
    Table 43. North America Decitabine Sales Market Share by Type (2016-2021)
    Table 44. North America Decitabine Sales by Type (2022-2027) & (K Units)
    Table 45. North America Decitabine Sales Market Share by Type (2022-2027)
    Table 46. North America Decitabine Sales by Application (2016-2021) & (K Units)
    Table 47. North America Decitabine Sales Market Share by Application (2016-2021)
    Table 48. North America Decitabine Sales by Application (2022-2027) & (K Units)
    Table 49. North America Decitabine Sales Market Share by Application (2022-2027)
    Table 50. Europe Decitabine Sales (K Units) by Company (2016-2021)
    Table 51. Europe Decitabine Sales Market Share by Company (2016-2021)
    Table 52. Europe Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Decitabine Revenue Market Share by Company (2016-2021)
    Table 54. Europe Decitabine Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Decitabine Sales Market Share by Type (2016-2021)
    Table 56. Europe Decitabine Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Decitabine Sales Market Share by Type (2022-2027)
    Table 58. Europe Decitabine Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Decitabine Sales Market Share by Application (2016-2021)
    Table 60. Europe Decitabine Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Decitabine Sales Market Share by Application (2022-2027)
    Table 62. China Decitabine Sales (K Units) by Company (2016-2021)
    Table 63. China Decitabine Sales Market Share by Company (2016-2021)
    Table 64. China Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Decitabine Revenue Market Share by Company (2016-2021)
    Table 66. China Decitabine Sales by Type (2016-2021) & (K Units)
    Table 67. China Decitabine Sales Market Share by Type (2016-2021)
    Table 68. China Decitabine Sales by Type (2022-2027) & (K Units)
    Table 69. China Decitabine Sales Market Share by Type (2022-2027)
    Table 70. China Decitabine Sales by Application (2016-2021) & (K Units)
    Table 71. China Decitabine Sales Market Share by Application (2016-2021)
    Table 72. China Decitabine Sales by Application (2022-2027) & (K Units)
    Table 73. China Decitabine Sales Market Share by Application (2022-2027)
    Table 74. Japan Decitabine Sales (K Units) by Company (2016-2021)
    Table 75. Japan Decitabine Sales Market Share by Company (2016-2021)
    Table 76. Japan Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Decitabine Revenue Market Share by Company (2016-2021)
    Table 78. Japan Decitabine Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Decitabine Sales Market Share by Type (2016-2021)
    Table 80. Japan Decitabine Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Decitabine Sales Market Share by Type (2022-2027)
    Table 82. Japan Decitabine Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Decitabine Sales Market Share by Application (2016-2021)
    Table 84. Japan Decitabine Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Decitabine Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Decitabine Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Decitabine Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Decitabine Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Decitabine Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Decitabine Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Decitabine Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Decitabine Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Decitabine Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Decitabine Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Decitabine Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Decitabine Sales Market Share by Application (2022-2027)
    Table 98. India Decitabine Sales (K Units) by Company (2016-2021)
    Table 99. India Decitabine Sales Market Share by Company (2016-2021)
    Table 100. India Decitabine Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Decitabine Revenue Market Share by Company (2016-2021)
    Table 102. India Decitabine Sales by Type (2016-2021) & (K Units)
    Table 103. India Decitabine Sales Market Share by Type (2016-2021)
    Table 104. India Decitabine Sales by Type (2022-2027) & (K Units)
    Table 105. India Decitabine Sales Market Share by Type (2022-2027)
    Table 106. India Decitabine Sales by Application (2016-2021) & (K Units)
    Table 107. India Decitabine Sales Market Share by Application (2016-2021)
    Table 108. India Decitabine Sales by Application (2022-2027) & (K Units)
    Table 109. India Decitabine Sales Market Share by Application (2022-2027)
    Table 110. Johnson & Johnson Corporation Information
    Table 111. Johnson & Johnson Description and Business Overview
    Table 112. Johnson & Johnson Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Johnson & Johnson Decitabine Product
    Table 114. Johnson & Johnson Recent Development
    Table 115. Eli Lilly and Company Corporation Information
    Table 116. Eli Lilly and Company Description and Business Overview
    Table 117. Eli Lilly and Company Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Eli Lilly and Company Decitabine Product
    Table 119. Eli Lilly and Company Recent Development
    Table 120. Pharmachemie B.V. Corporation Information
    Table 121. Pharmachemie B.V. Description and Business Overview
    Table 122. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Pharmachemie B.V. Decitabine Product
    Table 124. Pharmachemie B.V. Recent Development
    Table 125. Otsuka Pharmaceutical Corporation Information
    Table 126. Otsuka Pharmaceutical Description and Business Overview
    Table 127. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Otsuka Pharmaceutical Decitabine Product
    Table 129. Otsuka Pharmaceutical Recent Development
    Table 130. Sandoz Corporation Information
    Table 131. Sandoz Description and Business Overview
    Table 132. Sandoz Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Sandoz Decitabine Product
    Table 134. Sandoz Recent Development
    Table 135. Dr Reddy's Laboratories Corporation Information
    Table 136. Dr Reddy's Laboratories Description and Business Overview
    Table 137. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. Dr Reddy's Laboratories Decitabine Product
    Table 139. Dr Reddy's Laboratories Recent Development
    Table 140. Accord Healthcare Corporation Information
    Table 141. Accord Healthcare Description and Business Overview
    Table 142. Accord Healthcare Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Accord Healthcare Decitabine Product
    Table 144. Accord Healthcare Recent Development
    Table 145. Sun Pharmaceutical Corporation Information
    Table 146. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Sun Pharmaceutical Description and Business Overview
    Table 148. Sun Pharmaceutical Decitabine Product
    Table 149. Sun Pharmaceutical Recent Development
    Table 150. Cipla Corporation Information
    Table 151. Cipla Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 152. Cipla Description and Business Overview
    Table 153. Cipla Decitabine Product
    Table 154. Cipla Recent Development
    Table 155. Lupin Corporation Information
    Table 156. Lupin Description and Business Overview
    Table 157. Lupin Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 158. Lupin Decitabine Product
    Table 159. Lupin Recent Development
    Table 160. Shandong Xinshidai Pharmaceutical Corporation Information
    Table 161. Shandong Xinshidai Pharmaceutical Description and Business Overview
    Table 162. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 163. Shandong Xinshidai Pharmaceutical Decitabine Product
    Table 164. Shandong Xinshidai Pharmaceutical Recent Development
    Table 165. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
    Table 166. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
    Table 167. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 168. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product
    Table 169. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
    Table 170. ZHENGDA Tianqing Pharmaceutical Group Corporation Information
    Table 171. ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
    Table 172. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 173. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product
    Table 174. ZHENGDA Tianqing Pharmaceutical Group Recent Development
    Table 175. Jiangsu Aosaikang Pharmaceutical Corporation Information
    Table 176. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
    Table 177. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 178. Jiangsu Aosaikang Pharmaceutical Decitabine Product
    Table 179. Jiangsu Aosaikang Pharmaceutical Recent Development
    Table 180. Jiangsu Haosen Pharmaceutical Group Corporation Information
    Table 181. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
    Table 182. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 183. Jiangsu Haosen Pharmaceutical Group Decitabine Product
    Table 184. Jiangsu Haosen Pharmaceutical Group Recent Development
    Table 185. Lianyungang Jierui Pharmaceutical Corporation Information
    Table 186. Lianyungang Jierui Pharmaceutical Description and Business Overview
    Table 187. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 188. Lianyungang Jierui Pharmaceutical Decitabine Product
    Table 189. Lianyungang Jierui Pharmaceutical Recent Development
    Table 190. Qilu Pharmaceutical Hainan Corporation Information
    Table 191. Qilu Pharmaceutical Hainan Description and Business Overview
    Table 192. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 193. Qilu Pharmaceutical Hainan Decitabine Product
    Table 194. Qilu Pharmaceutical Hainan Recent Development
    Table 195. Lianyungang Runzhong Pharmaceutical Corporation Information
    Table 196. Lianyungang Runzhong Pharmaceutical Description and Business Overview
    Table 197. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 198. Lianyungang Runzhong Pharmaceutical Decitabine Product
    Table 199. Lianyungang Runzhong Pharmaceutical Recent Development
    Table 200. Production Base and Market Concentration Rate of Raw Material
    Table 201. Key Suppliers of Raw Materials
    Table 202. Decitabine Distributors List
    Table 203. Decitabine Customers List
    Table 204. Decitabine Market Trends
    Table 205. Decitabine Market Drivers
    Table 206. Decitabine Market Challenges
    Table 207. Decitabine Market Restraints
    Table 208. Research Programs/Design for This Report
    Table 209. Key Data Information from Secondary Sources
    Table 210. Key Data Information from Primary Sources
List of Figures
    Figure 1. Decitabine Product Picture
    Figure 2. Global Decitabine Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Decitabine Sales Market Share by Application in 2021 & 2027
    Figure 6. Primary MDS Examples
    Figure 7. Secondary MDS Examples
    Figure 8. Global Decitabine Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Decitabine Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Decitabine Sales (K Units) Growth Rate (2016-2027)
    Figure 11. Global Decitabine Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 12. Global Decitabine Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Decitabine Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Decitabine Sales (K Units) Growth Rate (2016-2027)
    Figure 16. Europe Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Decitabine Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Decitabine Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Decitabine Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Decitabine Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Decitabine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Decitabine Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Decitabine Players Market Share by Revenue in Decitabine: 2016 & 2020
    Figure 27. Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Decitabine Revenue Share by Type (2016-2021)
    Figure 29. Global Decitabine Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Decitabine Revenue Share by Application (2016-2021)
    Figure 31. Global Decitabine Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Decitabine Sales Market Share by Type in 2020
    Figure 33. North America Decitabine Sales Market Share by Application in 2020
    Figure 34. Europe Decitabine Sales Market Share by Type in 2020
    Figure 35. Europe Decitabine Sales Market Share by Application in 2020
    Figure 36. China Decitabine Sales Market Share by Type in 2020
    Figure 37. China Decitabine Sales Market Share by Application in 2020
    Figure 38. Japan Decitabine Sales Market Share by Type in 2020
    Figure 39. Japan Decitabine Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Decitabine Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Decitabine Sales Market Share by Application in 2020
    Figure 42. India Decitabine Sales Market Share by Type in 2020
    Figure 43. India Decitabine Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Decitabine 
    Figure 46. Manufacturing Process Analysis of Decitabine
    Figure 47. Decitabine Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Frequently Asked Questions
Decitabine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Decitabine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Decitabine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DBB Valve

The global DBB Valve market is segmented by company, region (country), by Type, and by Applicatio ... Read More

Clamp Ampere Meter

The global Clamp Ampere Meter market is segmented by company, region (country), by Type, and by A ... Read More